PerzJ.F., ArmstrongG.L., FarringtonL.A.The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol2006; 45: 529–538.
2.
WHO Executive Board.Viral hepatitis: report by the Secretariat, EB126/15. Geneva: World Health Organization2009.
Alvarado-MoraM.V., Rebello PinhoJ.R.Epidemiological update of hepatitis B, C and delta in Latin America. Antivir Ther2013; 18: 429–433.
5.
LampeE., Lewis-XimenezL., Espírito-SantoM.P.Genetic diversity of HCV in Brazil. Antivir Ther2013; 18: 435–444.
6.
KikuchiL., ChagasA.L., AlencarR.S.S.M., Paranaguá-VezozzoD.C., CarrilhoF.J.Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil. Antivir Ther2013; 18: 445–449.
7.
NúñezM., Mendes-CorreaM.C.Viral hepatitis and HIV: update and management. Antivir Ther2013; 18: 451–458.
8.
Alvarado-MoraM.V., Rebello PinhoJ.R.Distribution of HBV genotypes in Latin America. Antivir Ther2013; 18: 459–465.
9.
OsiowyC., SimonsB.C., RempelJ.D.Distribution of viral hepatitis in indigenous populations of North America and the circumpolar Arctic. Antivir Ther2013; 18: 467–473.
10.
PanduroA., Maldonado-GonzalezM., FierroN.A., RomanS.Distribution of HBV genotypes F and H in Mexico and Central America. Antivir Ther2013; 18: 475–484.
11.
MarcianoS., GaldameO.A., GadanoA.C.HBV genotype F: natural history and treatment. Antivir Ther2013; 18: 485–488.
12.
SimmondsP., MidgleyS.Recombination in the genesis and evolution of hepatitis B virus genotypes. J Virol2005; 79: 15467–15476.
13.
MuldersM.N., VenardV., NjayouM.Low genetic diversity despite hyperendemicity of hepatitis B virus genotype E throughout West Africa. J Infect Dis2004; 190: 400–408.
14.
FaresM.A., HolmesE.C.A revised evolutionary history of hepatitis B virus (HBV). J Mol Evol2002; 54: 807–814.
15.
TedderR.S., BissettS.L., MyersR., IjazS.The ‘Red Queen’ dilemma – running to stay in the same place: refections on the evolutionary vector of HBV in humans. Antivir Ther2013; 18: 489–496.
16.
BouckaertR., Alvarado-MoraM.V., Rebello PinhoJ.R.Evolutionary rates and HBV: issues of rate estimation with Bayesian molecular methods. Antivir Ther2013; 18: 497–503.
17.
GodoyB.A., Alvarado-MoraM.V., Gomes-GouvêaM.S., Rebello PinhoJ.R., FagundesN.J.R.Origin of HBV and its arrival in the Americas – the importance of natural selection on time estimates. Antivir Ther2013; 18: 505–512.
18.
KramvisA., ParaskevisD.Subgenotype A1 of HBV – tracing human migrations in and out of Africa. Antivir Ther2013; 18: 513–521.
19.
TaylorD.R.Evolution of cell culture systems for HCV. Antivir Ther2013; 18: 523–530.
20.
MoriconiF., BeardM.R., YuenL.K.W.Bioinformatics methods for the analysis of hepatitis viruses. Antivir Ther2013; 18: 531–539.
21.
Alvarado-MoraM.V., LocarniniS., RizzettoM., Rebello PinhoJ.R.An update on HDV: virology, pathogenesis and treatment. Antivir Ther2013; 18: 541–548.